Physician

Tzu-Chuan Jane Huang, MD

According to 2025 Medicare claims, Tzu-Chuan Huang, MD (NPI: 1962604066) practices hematology/oncology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Walton, GA. This provider's primary affiliated billing organization is UNIVERSITY CANCER & BLOOD CENTER LLC (NPI: 1346343761; TIN: 20-1842623) and primary practice location at 30607-1465.

Huang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 686 traditional Medicare patients, billed 114,213 HCPCS/CPT codes, and received $2,245,690 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,005 prescription claims across 226 beneficiaries totaling $3,782,552 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 35 claims. Open Payments data shows 24 records totaling $506. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $836,887 to $3,782,552. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $9,218 to $979.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	739	155,097	$1,428,281
2016	861	225,959	$1,916,988
2017	832	177,456	$1,924,971
2018	819	220,045	$2,652,776
2019	837	193,504	$2,753,566
2020	826	187,377	$2,476,625
2021	890	160,745	$2,170,861
2022	808	165,358	$2,548,610
2023	650	138,204	$1,965,168
2024	686	114,213	$2,245,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	176	1,256	$836,887
2016	222	1,388	$1,232,593
2017	226	1,438	$1,461,955
2018	254	1,579	$2,358,431
2019	291	1,725	$2,572,151
2020	314	1,828	$3,289,067
2021	316	1,783	$3,562,528
2022	263	1,183	$3,004,999
2023	237	1,057	$3,745,330
2024	226	1,005	$3,782,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	152	$9,127
2016	N/R	133	$9,168
2017	N/R	24	$4,892
2018	N/R	44	$4,466
2019	N/R	84	$4,923
2020	N/R	122	$5,778
2021	N/R	33	$2,084
2022	N/R	N/R	N/R
2023	N/R	35	$3,036
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	454	1,155	$92
36415	Insertion of needle into vein for collection of blood sample	376	1,049	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	350	982	$8
83615	Lactate dehydrogenase (enzyme) level	232	356	$6
84550	Uric acid level, blood	232	356	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	60	1,638	$1,244,707
Pomalyst	Pomalidomide	12	336	$259,299
Brukinsa	Zanubrutinib	16	480	$241,718
Tasigna	Nilotinib Hcl	12	336	$235,231
Verzenio	Abemaciclib	12	336	$173,777

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$506	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tzu-Chuan Jane Huang, MD?

Tedicare shows public-source Medicare data for Tzu-Chuan Jane Huang, MD (NPI 1962604066), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tzu-Chuan Jane Huang, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tzu-Chuan Jane Huang, MD?

Tzu-Chuan Jane Huang, MD is linked to UNIVERSITY CANCER & BLOOD CENTER LLC (billing NPI 1346343761) in the available physician profile data.

Does Tzu-Chuan Jane Huang, MD have Open Payments data?

Tzu-Chuan Jane Huang, MD has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.